Stemline Therapeutics Inc (STML.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|51||2003||Chairman of the Board, President, Chief Executive Officer|
|52||2013||Chief Operating Officer|
|56||2014||Chief Accounting Officer, Vice President - Finance|
- BRIEF-Stemline Therapeutics Inc - Co Launched An At-Market Offering Of Up To $50 Million Worth Of Shares
- BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93
- BRIEF-Stemline Therapeutics Prices $51.8 Mln Public Offering
- BRIEF-Stemline Therapeutics Announces Proposed Public Offering Of Common Stock
- BRIEF-Stemline Therapeutics reports Q3 loss per share $0.68